|
TLN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72268999999448E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.0269999995447E-07 |
| Normal-vs-Stage2 |
1.160200E-02 |
| Normal-vs-Stage3 |
2.682600E-03 |
| Normal-vs-Stage4 |
6.498400E-03 |
| Stage1-vs-Stage2 |
1.720620E-01 |
| Stage1-vs-Stage3 |
1.114650E-01 |
| Stage1-vs-Stage4 |
8.979000E-01 |
| Stage2-vs-Stage3 |
9.899200E-01 |
| Stage2-vs-Stage4 |
4.994600E-01 |
| Stage3-vs-Stage4 |
4.236000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.11730000005051E-06 |
| Normal-vs-AfricanAmerican |
1.033710E-04 |
| Normal-vs-Asian |
1.703650E-03 |
| Caucasian-vs-AfricanAmerican |
8.313400E-01 |
| Caucasian-vs-Asian |
3.373200E-01 |
| AfricanAmerican-vs-Asian |
4.175800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.96009999967551E-07 |
| Normal-vs-Female |
5.220600E-03 |
| Male-vs-Female |
1.029050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.214100E-04 |
| Normal-vs-Extreme_Weight |
6.70549999970405E-08 |
| Normal-vs-Obese |
5.684500E-03 |
| Normal-vs-Extreme_Obese |
2.217000E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.458000E-01 |
| Normal_Weight-vs-Obese |
2.164600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.232400E-01 |
| Extreme_Weight-vs-Obese |
9.897600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.100000E-01 |
| Obese-vs-Extreme_Obese |
1.226620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.618700E-03 |
| Normal-vs-Age(41-60Yrs) |
5.032100E-04 |
| Normal-vs-Age(61-80Yrs) |
5.92479999950157E-07 |
| Normal-vs-Age(81-100Yrs) |
7.560200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.988400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.566800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.936800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.165600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.657200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.560800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.61909999962795E-07 |
| Normal-VS-Type2 PRCC |
3.575500E-04 |
| Normal-VS-KIRP CIMP |
6.506000E-02 |
| Normal-VS-Unclassified PRCC |
1.923220E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.962000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.100200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.735960E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.833000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.056400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.269600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.75257999999179E-05 |
| Normal-vs-N1 |
4.016400E-03 |
| Normal-vs-N2 |
3.418000E-02 |
| N0-vs-N1 |
3.952600E-01 |
| N0-vs-N2 |
9.815800E-01 |
| N1-vs-N2 |
7.126600E-01 |
|
|
